Ishita Drugs and Industries Limited (BOM:524400)

Market Cap	211.56M -4.4%
Revenue (ttm)	146.60M -2.2%
Net Income	7.79M -10.3%
EPS	2.60 -10.3%
Shares Out	2.99M
PE Ratio	27.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	511
Open	75.00
Previous Close	75.00
Day's Range	70.75 - 75.75
52-Week Range	66.00 - 90.85
Beta	-0.32
Analysts	n/a
Price Target	n/a
Earnings Date	May 30, 2026

About BOM:524400

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in A...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1992
• Employees: 14
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524400

Financial Performance

In fiscal year 2026, BOM:524400's revenue was 146.60 million, a decrease of -2.25% compared to the previous year's 149.97 million. Earnings were 7.79 million, a decrease of -10.32%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 21, 2026

Data Sources Report a data error